LYZZ Capital
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Early Stage, Expansion Stage
Geographical Focus
United States, China
Industries Focus
- Healthcare
- Medical Devices
- Medical Services
- Medical Digitalization
Investor Details
LYZZ Capital is a prominent global healthcare-focused venture capital and private equity firm, managing over USD $600 million in funds. The firm invests in innovative talents, assets, and technologies worldwide, targeting unmet medical needs and significant market opportunities in China. Their portfolio spans healthcare, medical devices, medical services, and medical digitalization sectors.
The management team comprises experienced professionals from leading pharmaceutical and biotech companies, as well as Wall Street firms, with strong scientific and medical backgrounds. They have over 20 years of biotech investment experience, including more than 15 years in China, fostering a collaborative and team-oriented environment.
LYZZ Capital's investment strategy emphasizes value investing, business judgment, technology foresight, and market foresight, aiming to create sustainable value for all stakeholders.
Requirements
- Focus on unmet medical needs
- Large market potential in China
- Innovative healthcare technologies
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Mojia Biotech
- OncoMyx Therapeutics
- Onchilles Pharma
- Neurelis
- JumpCode Genomics
- Qpex Biopharma
Mentioned In
Claim this Investor
Are you an official representative of LYZZ Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim